# 2-HOBA Supplementation in People With Elevated Lipoprotein(a)

> **NCT07198009** · NA · NOT_YET_RECRUITING · sponsor: **The Miriam Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Hyperlipidemia
- Elevated Lp(a)

## Interventions

- **DIETARY_SUPPLEMENT:** 2-HOBA (Hobamine)

## Key facts

- **NCT ID:** NCT07198009
- **Lead sponsor:** The Miriam Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2026-03
- **Final completion:** 2026-11
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07198009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07198009, "2-HOBA Supplementation in People With Elevated Lipoprotein(a)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07198009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*